GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tempest Therapeutics Inc (STU:3OS) » Definitions » FCF Yield %

Tempest Therapeutics (STU:3OS) FCF Yield % : -58.83 (As of Jun. 23, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Tempest Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Tempest Therapeutics's Trailing 12-Month Free Cash Flow is €-24.52 Mil, and Market Cap is €42.13 Mil. Therefore, Tempest Therapeutics's FCF Yield % for today is -58.83%.

The historical rank and industry rank for Tempest Therapeutics's FCF Yield % or its related term are showing as below:

STU:3OS' s FCF Yield % Range Over the Past 10 Years
Min: -82.17   Med: 0   Max: 0
Current: -58.83


STU:3OS's FCF Yield % is ranked worse than
76.77% of 1550 companies
in the Biotechnology industry
Industry Median: -14.395 vs STU:3OS: -58.83

Tempest Therapeutics's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.


Tempest Therapeutics FCF Yield % Historical Data

The historical data trend for Tempest Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tempest Therapeutics FCF Yield % Chart

Tempest Therapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
FCF Yield %
- -74.75 -265.34 -27.13

Tempest Therapeutics Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -117.19 -183.63 -547.54 -24.37 -36.47

Competitive Comparison of Tempest Therapeutics's FCF Yield %

For the Biotechnology subindustry, Tempest Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tempest Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tempest Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Tempest Therapeutics's FCF Yield % falls into.



Tempest Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Tempest Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-25.242 / 93.031166
=-27.13%

Tempest Therapeutics's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-6.766 * 4 / 74.205782
=-36.47%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tempest Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Tempest Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Tempest Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tempest Therapeutics (STU:3OS) Business Description

Traded in Other Exchanges
Address
2000 Sierra Point Parkway, Suite 400, Brisbane, CA, USA, 94005
Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.

Tempest Therapeutics (STU:3OS) Headlines

No Headlines